EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evidence of blood–brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder

Jonathan D Santoro iD, Neetha Paul Eduthan, Mellad M Khoshnood, Saba Jafarpour, Natalie K Boyd, Benjamin N Vogel, Lina Nguyen, Lilia Kazerooni, Eleanor Britton, Hannah R Lyford, Matthew D Galbraith, Angela L Rachubinski und 1 weitere

Annals of Clinical and Translational Neurology · 2025

DOI: 10.1002/acn3.52299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Jonathan D Santoro und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Down Syndrome, Blood-Brain Barrier, Immunoglobulins, Neuroinflammatory Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Child Health and Human Development, NHLBI NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study sought to evaluate proteomic, metabolomic, and immune signatures in the cerebrospinal fluid of individuals with Down Syndrome Regression Disorder (DSRD).

Methods

A prospective case–control study comparing proteomic, metabolomic, and immune profiles in individuals with DSRD was performed. Samples were obtained from a biorepository of affected individuals and compared to clinically available data and previously obtained neurodiagnostic studies. Individuals with DSRD were compared to individuals with established neuroinflammatory conditions (e.g., multiple sclerosis), and neurotypical controls undergoing a lumbar puncture for headaches. Samples underwent high‐throughput proteomic, metabolomic, and immune marker profiling. Data was compared across groups and clinical phenotypes. Gene set enrichment analysis and pathway analyses were utilized to analyze the data.

Results

In total, 34 individuals with DSRD, 22 neuroinflammatory controls, and 27 neurotypical controls were enrolled in the study. We observed a highly significant concordance in dysregulated proteomics signatures in DSRD and neuroinflammatory controls versus healthy controls, most prominently upregulation of many immunoglobulin sequences. In addition, individuals with DSRD displayed strong upregulation of liver‐derived plasma proteins and erythrocyte proteins in the CSF, indicating poor blood–brain barrier integrity. The immune marker profile of DSRD is clearly similar to other neuroimmunological conditions, including strong elevation of MIP3‐α, eotaxin, and IFN‐γ.

Interpretation

Individuals with DSRD have unique CSF proteomic and metabolomic signatures consistent with neuroinflammation and increased blood–brain barrier permeability. The CSF of individuals with DSRD was more comparable to individuals with neuroinflammatory disorders than neurotypical controls, indicating the potential for an immune etiology of disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeBlood-Brain BarrierImmunoglobulinsNeuroinflammatory DiseasesHumansFemaleMaleAdultCase-Control StudiesYoung AdultProteomicsProspective StudiesAdolescentBiomarkersMiddle Aged

Substanzen

ImmunoglobulinsBiomarkers

Autor:innen und Institutionen

  • Division of Neurology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Department of Neurology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
  • Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Division of Developmental Pediatrics, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

ORCID-Profile: Jonathan D Santoro

Förderung

  • National Institute of Child Health and Human Development
  • NHLBI NIH HHS
  • NICHD NIH HHS
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Santoro, J. D., Eduthan, N. P., Khoshnood, M. M., Jafarpour, S., Boyd, N. K., Vogel, B. N., Nguyen, L., Kazerooni, L., Britton, E., Lyford, H. R., Galbraith, M. D., Rachubinski, A. L., & Espinosa, J. M. (2025). Evidence of blood–brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52299

Vancouver

Santoro JD, Eduthan NP, Khoshnood MM, Jafarpour S, Boyd NK, Vogel BN, et al. Evidence of blood–brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.52299

BibTeX
@article{Santoro2025,
  author = {Santoro, Jonathan D and Eduthan, Neetha Paul and Khoshnood, Mellad M and Jafarpour, Saba and Boyd, Natalie K and Vogel, Benjamin N and Nguyen, Lina and Kazerooni, Lilia and Britton, Eleanor and Lyford, Hannah R and Galbraith, Matthew D and Rachubinski, Angela L and Espinosa, Joaquin M},
  title = {Evidence of blood–brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  doi = {10.1002/acn3.52299}
}
Kostenlos starten →